Clinical Trial Update: Efficacy and Tolerance of Tocilizumab In Takayasu Arteritis [Phase 3]

View source ↗

Summary

Phase 3 trial update evaluating the efficacy and tolerability of tocilizumab in Takayasu arteritis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Takayasu Arteritis

Drugs mentioned

• Tocilizumab (tocilizumab)

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: TAKAYASU ARTERITIS | Phase 3 | Status: COMPLETED